10x Genomics, Inc. (TXG) on GreekSoup https://greeksoup.ai/stocks/us/txg/ Every dated entry in the public record on 10x Genomics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 10x Genomics, Inc.: short interest 12,732,231 shares at the 15 October 2026 settlement, 2.65 days to coverhttps://greeksoup.ai/stocks/us/txg/short-interest/us:TXG:short-interest:2026-10-15:34ae5dd90eThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Schedule 13G/A filed by ARK Investment Management LLC, 5.2% of the classhttps://greeksoup.ai/stocks/us/txg/holders/us:TXG:schedule-13:2026-10-07:55a72bbb40Wed, 07 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: short interest 15,371,598 shares at the 30 September 2026 settlement, 4.53 days to coverhttps://greeksoup.ai/stocks/us/txg/short-interest/us:TXG:short-interest:2026-09-30:a91cedc1d2Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Suliman Shehnaaz (Director) sold 292 shares (under a trading plan set in advance) at $78.20 on 22 September 2026, $22,833https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:aeb105bbdbThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Suliman Shehnaaz (Director) sold 614 shares (under a trading plan set in advance) at $79.51 on 22 September 2026, $48,820https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:399fc3d4d9Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Suliman Shehnaaz (Director) sold 1,325 shares (under a trading plan set in advance) at $80.82 on 22 September 2026, $107,082https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:9e671e4fdaThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Suliman Shehnaaz (Director) sold 2,270 shares (under a trading plan set in advance) at $81.67 on 22 September 2026, $185,391https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:ca1b54b017Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Suliman Shehnaaz (Director) sold 1,222 shares (under a trading plan set in advance) at $82.28 on 22 September 2026, $100,542https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:ac9fb4fc48Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 1,000 shares (under a trading plan set in advance) at $78.23 on 22 September 2026, $78,228https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:86e152e209Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 2,000 shares (under a trading plan set in advance) at $79.62 on 22 September 2026, $159,239https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:b9e56d5654Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 9,300 shares (under a trading plan set in advance) at $80.90 on 22 September 2026, $752,401https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:63fa50c790Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 9,900 shares (under a trading plan set in advance) at $81.83 on 22 September 2026, $810,071https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:7f1adae29dThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 2,800 shares (under a trading plan set in advance) at $82.36 on 22 September 2026, $230,622https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-24:7fa0f5ff84Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, Shehnaaz Suliman plans to sell 5,723 shares worth $452,689 around 22 September 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-09-22:a7d93dc0beTue, 22 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: short interest 16,692,300 shares at the 15 September 2026 settlement, 7.09 days to coverhttps://greeksoup.ai/stocks/us/txg/short-interest/us:TXG:short-interest:2026-09-15:bbdd3de743Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Taich Adam (Chief Financial Officer) sold 1,206 shares (under a trading plan set in advance) at $63.68 on 9 September 2026, $76,795https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-11:184155a6b1Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Taich Adam (Chief Financial Officer) sold 31,428 shares (under a trading plan set in advance) at $64.31 on 9 September 2026, $2.0 millionhttps://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-11:daa6d200b6Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Taich Adam (Chief Financial Officer) sold 13,754 shares (under a trading plan set in advance) at $65.26 on 9 September 2026, $897,550https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-11:3510af4798Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, ADAM TAICH plans to sell 46,388 shares worth $3.0 million around 9 September 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-09-09:a1492fecbbWed, 09 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Schedule 13G filed by T. Rowe Price Associates, Inc., 11.7% of the classhttps://greeksoup.ai/stocks/us/txg/holders/us:TXG:schedule-13:2026-09-08:90326dcc25Tue, 08 Sep 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Stuelpnagel John R (Director) sold 7,012 shares at $60.66 on 3 September 2026, $425,333https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-08:724f6773f2Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Stuelpnagel John R (Director) sold 6,814 shares at $62.11 on 3 September 2026, $423,205https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-08:4e9de1d7baTue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Stuelpnagel John R (Director) sold 6,174 shares at $62.61 on 3 September 2026, $386,533https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-09-08:33a9036eb0Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, STUELPNAGEL JOHN R plans to sell 20,000 shares worth $1.2 million around 3 September 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-09-03:d998fe30adThu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: short interest 16,161,855 shares at the 31 August 2026 settlement, 5.51 days to coverhttps://greeksoup.ai/stocks/us/txg/short-interest/us:TXG:short-interest:2026-08-31:2c01bc07acMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 3,500 shares (under a trading plan set in advance) at $63.02 on 26 August 2026, $220,580https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-28:98c6b19261Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 6,494 shares (under a trading plan set in advance) at $63.98 on 26 August 2026, $415,465https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-28:635795a60eFri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 492 shares (under a trading plan set in advance) at $64.75 on 26 August 2026, $31,855https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-28:cc19c76314Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, Serge Saxonov plans to sell 35,486 shares worth $2.2 million around 26 August 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-08-26:014e951f84Wed, 26 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Saxonov Serge (Chief Executive Officer) sold 18,545 shares at $63.02 on 24 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-26:6210e6406cWed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Taich Adam (Chief Financial Officer) sold 17,166 shares at $63.02 on 24 August 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-26:81817f8713Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Hindson Benjamin J. (See Remarks) sold 13,818 shares at $63.02 on 24 August 2026, $870,860https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-26:2bc6f4761bWed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Suliman Shehnaaz (Director) sold 561 shares (under a trading plan set in advance) at $62.73 on 24 August 2026, $35,189https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-26:b6aeff2730Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Suliman Shehnaaz (Director) sold 1,646 shares (under a trading plan set in advance) at $63.97 on 24 August 2026, $105,289https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-26:a84795902bWed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, Shehnaaz Suliman plans to sell 2,207 shares worth $143,720 around 24 August 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-08-24:83bd712d6dMon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, Hindson Benjamin J. plans to sell 13,373 shares worth $870,850 around 24 August 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-08-24:a624c1603eMon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, Taich Adam plans to sell 16,614 shares worth $1.1 million around 24 August 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-08-24:0e23d70946Mon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, Saxonov Serge plans to sell 17,948 shares worth $1.2 million around 24 August 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-08-24:1f7299f5e7Mon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Teichmann Sarah A. (Director) sold 2,273 shares (under a trading plan set in advance) at $57.15 on 14 August 2026, $129,902https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-17:59669da9c1Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Teichmann Sarah A. (Director) sold 5,278 shares (under a trading plan set in advance) at $57.29 on 13 August 2026, $302,377https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-17:42a89a2199Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, SARAH A POLONIUS-TEICHMANN plans to sell 2,273 shares worth $129,902 around 14 August 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-08-14:084066c8aaFri, 14 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Schedule 13G/A filed by ARK Investment Management LLC, 8.6% of the classhttps://greeksoup.ai/stocks/us/txg/holders/us:TXG:schedule-13:2026-08-14:f504fb83b7Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: short interest 15,927,548 shares at the 14 August 2026 settlement, 4.57 days to coverhttps://greeksoup.ai/stocks/us/txg/short-interest/us:TXG:short-interest:2026-08-14:83e4b106ffFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, SARAH A POLONIUS-TEICHMANN plans to sell 5,278 shares worth $302,377 around 13 August 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-08-13:07ad4571b3Thu, 13 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Stuelpnagel John R (Director) sold 17,000 shares at $57.58 on 11 August 2026, $978,880https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-13:ee965813c6Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Stuelpnagel John R (Director) sold 3,000 shares at $58.73 on 11 August 2026, $176,175https://greeksoup.ai/stocks/us/txg/insiders/us:TXG:insider:2026-08-13:0cd598773fThu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: Form 144, STUELPNAGEL JOHN R plans to sell 20,000 shares worth $1.2 million around 11 August 2026https://greeksoup.ai/stocks/us/txg/planned-sales/us:TXG:planned-sale:2026-08-11:5848c771a5Tue, 11 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc. Q2 FY2026 results: revenue $151 million, net income -$18 millionhttps://greeksoup.ai/stocks/us/txg/results/fy2026-q2/us:TXG:result:2026-08-07:dfada9a5a7Fri, 07 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/txg/filings/us:TXG:filing:2026-08-07:b1cc072e87Fri, 07 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/txg/filings/us:TXG:filing:2026-08-06:e42b744f39Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> 10x Genomics, Inc.: short interest 15,625,594 shares at the 31 July 2026 settlement, 5.79 days to coverhttps://greeksoup.ai/stocks/us/txg/short-interest/us:TXG:short-interest:2026-07-31:6a578f8e46Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>